[Optimal dosage of furosemide in patients treated with repeated dialysis].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to P Simon.
Explore the source record for details and available documents.
The authors analyze 107 cases of recurrent ulcer after vagotomy. This study suggests that the most common cause is incomplete vagotomy and, more rarely, defective gastric drainage. The therapeutic deductions depend on the etiology. The most logical attitude is verification of the initial vagotomy associated with antrectomy without forgetting the successes obtained by simple thoracic vagotomy when wide gastric resection has already been carried out.
This pilot stuyd was made in order to search for the efficiency of an anticholinergic antiparkinsonian drug, orphenadrine, at high doses (300 to 500 mg/day, orally) in 10 depressed patients. This efficiency seems to be clear and appears quickly: with melancolic patients in particular, we observed 4 very good results in less than 5 days. Nevertheless, besides peripheral anticholinergic side-effects a transitory but very marked spatio-temporal disorganization, with increase of locomotor-activity and sometimes hallucinations, was observed in most patients. Nevertheless, it seems that this therapeutic should be carried on whenever other antidepressant therapeutics failed.
The authors report a stab wound of the right branch of the portal vein observed at the Lariboisière hospital, and discuss 27 published cases of traumatic lesions of the portal vein or its branches. The treatment of choice of these lesions is mainly suture, which is the best procedure when there is a frank lesion without loss of tissue. Furthermore, we have found that ligature of one branch of the portal vein is possible, even if one does not carry out removal of the liver in the corresponding area. On the other hand, in no case, in a patient without liver disease or portal hypertension, should one carry out sudden total interruption of the portal blood flow.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.